MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia"

  • 2023 International Congress

    Depression in Parkinson’s disease is associated with subcortical neurodegeneration and increased risk of all-cause mortality and dementia

    J. Badenoch, A. Paris, B. Jacobs, A. Noyce, C. Marshall, S. Waters (London, United Kingdom)

    Objective: To evaluate the temporality, neuroanatomical correlates and prognostic significance of depression in PD using a large population cohort. Background: Depression may be an important…
  • 2023 International Congress

    Thymoquinone and Edible Bird Nest: The Secret Ingredients to Protect Against MPTP-induced zebrafish Parkinson’s disease

    W. Mohamed (Kuantan, Malaysia)

    Objective: Objectives: to create and validate an MPTP neurotoxin-based zebrafish model of Parkinson's disease and explore the therapeutic potential and neuroprotective effects of thymoquinone and…
  • 2023 International Congress

    Yet another cause of Corticobasal Syndrome: A case of TREM2 related Alzheimer’s Disease presenting as Corticobasal Syndrome

    R. Todd, S. Doherty, B. Herron, Z. Janmuktane, K. Doherty (Belfast, United Kingdom)

    Objective: We present a case of corticobasal syndrome associated with a variant in the gene triggering receptor expressed on myeloid cells 2 (TREM2) and present…
  • 2023 International Congress

    Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: To investigate the role of depletion or excess of various heavy metals on clinical characteristics of Parkinson's disease (PD) developing PD dementia in drug-naïve…
  • 2023 International Congress

    10 year longitudinal change in clinical and biological characteristics of sporadic Parkinson Disease PPMI cohort

    P. Gonzalez-Latapi, T. Simuni, A. Siderowf, J. Fedler, M. Brumm, C. Gochanour, C. Coffey, K. Marek (Chicago, USA)

    Objective: To present data on 10 year longitudinal clinical and biological characteristics of sporadic Parkinson Disease (sPD) participants in the Parkinson’s Progression Markers Initiative (PPMI)…
  • 2023 International Congress

    Sex differences for clinicopathological correlations in people with Lewy body pathology

    E. Bayram, D. Coughlin, I. Litvan (La Jolla, USA)

    Objective: To determine sex-specific clinical correlations of different Lewy body (LB), Alzheimer’s disease (AD) pathology staging and nigral neuron loss levels in people with LB…
  • 2023 International Congress

    Creutzfeldt-Jakob Disease misdiagnosed as Corticobasal degeneration

    M. Elkasaby, C. Duffy, B. Appleby (Cleveland, USA)

    Objective: We described clinical, radiologic, and neuropathological findings of a patient with Creutzfeldt-Jakob Disease who presented antemortem with clinical features suggestive of corticobasal degeneration. Background:…
  • 2023 International Congress

    Extent of cognitive impairment in Parkinson`s disease with Covid-19

    B. Muminov, E. Abduqodirov, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study of the extent of cognitive impairment in PD patients with Covid-19. Background: Covid-19 may aggravate the clinical course of Parkinson's disease (PD)…
  • 2023 International Congress

    Effect of Sex on the association between GBA mutations and Cognitive Decline in Parkinson’s Disease

    SP. Caminiti, M. Avenali, M. Inglese, C. Tassorelli, D. Perani (Pavia, Italy)

    Objective: To assess the impact of sex and glucocerebrosidase (GBA) mutations on cognitive trajectories in a sample of Parkinson's disease (PD) patients. Background: Accumulating evidence…
  • 2023 International Congress

    Amyloid status differentiates synaptic loss and atrophy in Corticobasal Syndrome.

    N. Holland, G. Savulich, P. Jones, D. Whiteside, D. Street, M. Naessens, M. Malpetti, Y. Hong, T. Fryer, T. Rittman, E. Mulroy, F. Aigbirhio, K. Bhatia, J. O'Brien, J. Rowe (Cambridge, United Kingdom)

    Objective: In this observational/cross-sectional study, we tested whether the degree and extent of in vivo synaptic loss differed in patients with corticobasal syndrome according to…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29077 (not found)
  • #29056 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28189 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley